US2005226844A1PendingUtilityA1

Valency platform molecules comprising carbamate linkages

54
Assignee: JOLLA PHARMAPriority: Dec 9, 1998Filed: Jun 10, 2005Published: Oct 13, 2005
Est. expiryDec 9, 2018(expired)· nominal 20-yr term from priority
Inventors:David S. Jones
C07C 271/16C07D 249/08C07C 233/69C07D 295/205C07D 231/12C07D 233/56C07C 271/20
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention pertains generally to valency molecules, such as valency platform molecules which act as scaffolds to which one or more molecules may be covalently tethered to form a conjugate. More particularly, the present invention pertains to valency platform molecules which comprise a carbamate linkage (i.e., —O—C(═O)—N<). In one aspect, the present invention pertains to valency platforms comprising carbamate linkages, which molecules have the structure of any one of Formulae I, II, or III, shown in FIG. 1. In one aspect, the present invention pertains to valency platforms comprising carbamate linkages, which molecules have the structure of any one of Formulae IV, V, or VI, shown in FIG. 8. The present invention also pertains to methods of preparing such valency platform molecules, conjugates comprising such valency platform molecules, and methods of preparing such conjugates.

Claims

exact text as granted — not AI-modified
1 - 37 . (canceled)  
   
   
       38 . A composition comprising valency platform molecules, wherein each said valency platform molecule comprises at least 2 carbamate linkages and at least 4 reactive conjugating functional groups; and 
 wherein said valency platform molecules have a polydispersity less than about 1.2.    
   
   
       39 . The composition of  claim 38 , wherein said valency platform molecules have a polydispersity less than about 1.07.  
   
   
       40 . The composition of  claim 38 , wherein each said valency platform molecules comprises at least 4 carbamate linkages and at least 8 reactive functional groups.  
   
   
       41 . The composition of  claim 38 , wherein each said valency platform molecule comprises at least 4 identical reactive conjugating functional groups.  
   
   
       42 . The composition of  claim 38 , wherein each said valency platform molecule comprises 2 to 32 carbamate linkages and 4 to 64 reactive functional groups.  
   
   
       43 . The composition of  claim 38 , wherein comprising said valency platform molecules linked via said reactive functional groups to one or more biologically active molecules.  
   
   
       44 . A composition comprising valency molecules, wherein each said valency molecule comprises at least two branches and at least four terminal groups; 
 wherein each said valency molecule comprises at least 2 carbamate linkages; and    wherein said valency molecules have a polydispersity less than about 1.2.    
   
   
       45 . The composition of  claim 44 , wherein said valency molecules have a polydispersity less than about 1.07.  
   
   
       46 . The composition of  claim 44 , wherein said valency molecules comprise at least 4 carbamate linkages, at least 4 branches and at least 8 terminal groups.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.